Company · CIK 0001835205
IBERE PHARMACEUTICALS
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Cayman Islands
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001104659-23-022265 · 275.2 KBSEC(opens sec.gov)
- SC 13GIBERE PHARMACEUTICALS0001076809-23-000098 · 66.4 KBSEC(opens sec.gov)
- SC 13G/AIBERE PHARMACEUTICALS0001104659-23-020776 · 137.4 KBSEC(opens sec.gov)
- SC 13GIBERE PHARMACEUTICALS0001393825-23-000095 · 61.4 KBSEC(opens sec.gov)
- SC 13G/AIBERE PHARMACEUTICALS0000899140-23-000137 · 45.9 KBSEC(opens sec.gov)
- SC 13G/AIBERE PHARMACEUTICALS0001104659-23-009731 · 136.7 KBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-22-003339 · 5.2 MBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-22-002405 · 5.0 MBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-22-001616 · 4.3 MBSEC(opens sec.gov)
- 10-KAnnual report0001410578-22-000776 · 5.4 MBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
2005 MARKET STREET, SUITE 2030
PHILADELPHIA, PA, 19103
mailing
2005 MARKET STREET, SUITE 2030
PHILADELPHIA, PA, 19103
Same industry